The risk of SARS‐CoV‐2 infection through sexual contact should be investigated: A timely call

The risk of SARS‐CoV‐2 infection through sexual contact should be investigated: A timely call

Bibliographic Details
Main Author:	Syed Masudur Rahman Dewan
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	Immunity, Inflammation and Disease
Online Access:	https://doi.org/10.1002/iid3.971

Similar Items

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
by: Qiao Wang, et al.
Published: (2023-03-01)

Investigating the relationship between interventions, contact patterns, and SARS-CoV-2 transmissibility
by: Filippo Trentini, et al.
Published: (2022-09-01)

SARS-CoV-2 Pandemic: Should Children Wear Masks?
by: Joana Valente Dias, et al.
Published: (2020-10-01)

SARS-CoV-2 virus transfers to skin through contact with contaminated solids
by: Saeed Behzadinasab, et al.
Published: (2021-11-01)

RETRACTED: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
by: Yong Guo, et al.
Published: (2021-02-01)

Why Italian ENT physicians should be aware of SARS-CoV-2
by: Sara Torretta, et al.
Published: (2020-04-01)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
by: J. Matías-Guiu, et al.
Published: (2020-04-01)

Retraction: Glucocorticoids Should Be Used With Caution in Patients With SARS-CoV-2
by: Frontiers Editorial Office
Published: (2022-05-01)

Airborne transmission of SARS-CoV-2: The world should face the reality
by: Lidia Morawska, et al.
Published: (2020-06-01)

The United States Should Consider Compulsory SARS-CoV-2 Vaccination
by: Margaret Bove
Published: (2020-05-01)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
by: Yao J, et al.
Published: (2021-08-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
by: Rajat Goyal, et al.
Published: (2022-09-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
by: Huan Zhou, et al.
Published: (2021-12-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
by: Roney, Miah, et al.
Published: (2024)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
by: Eskild Petersen, et al.
Published: (2021-05-01)

What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
by: Miguel Angel Martinez
Published: (2022-02-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

SARS-CoV-2-related pangolin coronavirus exhibits similar infection characteristics to SARS-CoV-2 and direct contact transmissibility in hamsters
by: Zhendong Guo, et al.
Published: (2022-06-01)

Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
by: Hossam M. Ashour, et al.
Published: (2020-03-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
by: Lucas, TCD, et al.
Published: (2021)

The spreading of SARS-CoV-2: Interage contacts and networks degree distribution.
by: Lucas Sage, et al.
Published: (2021-01-01)

Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.
by: Rachel M Burke, et al.
Published: (2020-01-01)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021-01-01)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
by: Taniya Bhardwaj, et al.
Published: (2023-02-01)

How Long Should the Prone Position be Applied in the Treatment of SARS-CoV-2 ARDS?
by: Tuğba Yücel, et al.
Published: (2024-03-01)

Before blaming SARS-CoV-2 for GBS, other causes should be ruled out
by: Josef Finsterer, et al.
Published: (2023-01-01)

Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site
by: Josef Finsterer
Published: (2022-11-01)

Standards for the treatment of juvenile, ischemic stroke should not be abandoned for SARS-CoV-2 positives
by: Josef Finsterer, MD, PhD
Published: (2023-01-01)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
by: Shayan Rahmani, et al.
Published: (2022-05-01)

Should We Be Worried About Clostridioides difficile During the SARS-CoV2 Pandemic?
by: Eliane de Oliveira Ferreira, et al.
Published: (2020-09-01)

The Comparison of SARS-CoV-2, SARS-CoV, and MERS-CoV Genome and Spike Protein Variations
by: Choirun Nita Fikriani, et al.
Published: (2021-03-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
by: Karima A. Al-Salihi, et al.
Published: (2021-01-01)

Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells
by: Susanna K.P. Lau, et al.
Published: (2020-12-01)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
by: Yetian Dong, et al.
Published: (2020-10-01)

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
by: Ritesh Gorkhali, et al.
Published: (2021-06-01)